RATIONALE: Inaccurate beta-lactam allergy (BLA) labeling is associated with worse clinical outcomes due to over-avoidance of beta-lactam antibiotics. Although BLA de-labeling with penicillin skin testing (PST) can increase beta-lactam use, it is not readily available at many hospitals. There is a need to assess beta-lactam administration patterns at hospitals without readily available PST to identify potential areas for improvement. METHODS: Admission records of 282 patients with listed BLA who required antibiotics during hospitalization between June 2017 and July 2018 at a safety-net hospital with limited access to inpatient PST were reviewed retrospectively. RESULTS: Full doses of beta-lactams were administered without reaction in 73.0% [157/215] CONCLUSIONS: Beta-lactam administration was higher than expected, with full doses of penicillin and cephalosporin antibiotics administered without reaction in many patients with documented PA, including patients with documented penicillin anaphylaxis. Further investigation is needed into provider beliefs surrounding BLA cross-reactivity and the role of PST at this hospital, and their impact on beta-lactam administration practices.
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Study of sensitization to quinolone drugs Maria-Jose Sanchez-Gonzalez, MD, Jose Barbarroja-Escudero, MD, Ana Ant on-Laiseca, MD, Maria Angeles Ortega-Berruezo, Teodora Matas-Dominguez, and Mercedes Rodriguez-Rodriguez, MD; Principe de Asturias University Hospital, Alcala de Henares, Spain. RATIONALE: Quinolone antibiotics represent the second most used group of antibiotics. Ciprofloxacin is the second most prescribed antibiotic in USA. We present a group of 39patients with a complete study of 3quinolones in order to asses hypersensitivity to these drugs. METHODS: We performed skin prick tests (SPT) and intradermal tests (IDT) with different concentrations of 3quinolones. Ciprofloxacin: SPT 2mg/ml,IDT 0.02mg/ml; levofloxacin: SPT 5mg/ml, IDT 0.05mg/ml; moxifloxacin: SPT 4mg/ml. The patients underwent placebo controlled drug provocation tests (PCDPT) when needed. RESULTS: The 39patients (34female/5male), with a median age of 55.3(17-93) , referred an adverse reaction with the following quinolones: ciprofloxacin (22patients), levofloxacin (11p) and moxifloxacin (6p). The symptoms were pruritus along with urticaria (15p), angioedema (4p), urticaria/angioedema (4p), exanthema (7p), erythema (3p), anaphylaxis (6). We diagnosed the 6cases of anaphylaxis after convincing history, 3 were due to moxifloxacin (1 with positive SPT) and 3 due to ciprofloxacin (2 with positive tests). Diagnosis obtained: Ciprofloxacin: SPT:1, IDT:15, PCDPT:5, anamnesis:1. Levofloxacin: SPT:2, IDT:6, PCDPT:3. Moxifloxacin: SPT:3, PCDPT:2, anamnesis:1. Allergy to ciprofloxacin (22p); 14 tolerarated levofloxacin, 3 moxifloxacin, 5 both.
Allergy to levofloxacin (11p); 7 tolerated ciprofloxacin, 1 moxifloxacin ,2 both. Allergy to moxifloxacin (6p); 2 tolerated ciprofloxacin, 1 levofloxacin, 2 both. CONCLUSIONS: Skin tests are useful to study the sensitization to quinolone drugs. The study should be performed at least with two different quinolones, based on our series results; with tolerance to levofloxacin in patients sensitized to ciprofloxacin and good tolerance to ciprofloxacin among patients sensitized to levofloxacin. RATIONALE: Graded challenges (GC) may be as safe as penicillin skin testing (PST) in low risk patients. We designed a longitudinal, noninferiority trial to evaluate PST followed by an amoxicillin challenge compared to a 2-step GC to amoxicillin without PST. METHODS: Penicillin allergy histories were reviewed in all patients presenting to an allergy/immunology practice from 4/2018 onward. Patients >5 years old (y/o) with a cutaneous-only or unknown reaction (> 1 year ago for ages 5-17, > 10 years ago for 18+) were randomized 1:1 to PST or GC. All children <5 y/o underwent graded challenge and patients with extra-cutaneous reaction histories underwent PST. All groups were monitored 30 minutes after amoxicillin administration for reactions. Preliminary descriptive results are reported using means (SD) and percentages. RESULTS: Penicillin allergy was reported in 256/1622 (15.8%) patients, 139 consented to further evaluation. 13/256 (5.1%) patients <5 y/o underwent direct challenge; all were negative. 10/256 (3.9%) patients with angioedema and/or extra-cutaneous symptoms underwent PST; 1/10 patients had positive PST. A total of 116 patients were randomized to GC (49.1%) or PST (50.9%). SPT was negative in 53/59 (89.8%) patients. All 53 patients had a negative amoxicillin challenge. GC was negative in 56/57 (98.2%) patients. Average time for patients undergoing PST was 72.7 (6 5.2) minutes, and 68.4 (6 13.6) minutes for patients undergoing GC. CONCLUSIONS: Preliminary results demonstrate a low reaction rate among GC patients. Future non-inferiority analysis upon completion of this trial may provide foundational evidence for use of GC instead of PST in low risk patients.
